Foster Dykema Cabot & Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $787K | Buy |
4,240
+554
| +15% | +$103K | 0.06% | 61 |
|
|
2025
Q1 | $772K | Sell |
3,686
-38
| -1% | -$7.96K | 0.06% | 57 |
|
|
2024
Q4 | $662K | Sell |
3,724
-76
| -2% | -$13.5K | 0.05% | 70 |
|
|
2024
Q3 | $750K | Buy |
3,800
+635
| +20% | +$125K | 0.06% | 63 |
|
|
2024
Q2 | $543K | Buy |
3,165
+114
| +4% | +$19.6K | 0.05% | 61 |
|
|
2024
Q1 | $556K | Sell |
3,051
-5
| -0.2% | -$910 | 0.05% | 61 |
|
|
2023
Q4 | $474K | Buy |
+3,056
| New | +$474K | 0.05% | 60 |
|